📗 Cite This Artifact
RPL3 — Ribosomal Protein L3
RPL3 — Ribosomal Protein L3
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">rpl3</th>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">28S rRNA</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">RPL5</td>
<td>Protein interaction</td>
</tr>
<tr>
<td class="label">RPL11</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">eEF-1A</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">eEF-2</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">RPL23</td>
<td>Ribosomal protein interaction</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Known Target</td>
</tr>
<tr>
<td class="label">Rapamycin</td>
<td>mTORC1</td>
</tr>
<tr>
<td class="label">ISRIB</td>
<td>eIF2α</td>
</tr>
<tr>
<td class="label">Ribavirin</td>
<td>eIF4E</td>
</tr>
<tr>
RPL3 — Ribosomal Protein L3
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">rpl3</th>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">28S rRNA</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">RPL5</td>
<td>Protein interaction</td>
</tr>
<tr>
<td class="label">RPL11</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">eEF-1A</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">eEF-2</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">RPL23</td>
<td>Ribosomal protein interaction</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Known Target</td>
</tr>
<tr>
<td class="label">Rapamycin</td>
<td>mTORC1</td>
</tr>
<tr>
<td class="label">ISRIB</td>
<td>eIF2α</td>
</tr>
<tr>
<td class="label">Ribavirin</td>
<td>eIF4E</td>
</tr>
<tr>
<td class="label">Gadolinium</td>
<td>Ribosome</td>
</tr>
<tr>
<td class="label">Organism</td>
<td>RPL3 Homolog</td>
</tr>
<tr>
<td class="label">S. cerevisiae</td>
<td>RPL3</td>
</tr>
<tr>
<td class="label">D. melanogaster</td>
<td>RpL3</td>
</tr>
<tr>
<td class="label">C. elegans</td>
<td>rpl-3</td>
</tr>
<tr>
<td class="label">D. rerio</td>
<td>rpl3</td>
</tr>
<tr>
<td class="label">M. musculus</td>
<td>Rpl3</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
Gene Symbol: RPL3 (Ribosomal Protein L3) Chromosomal Location: 22q12.1 NCBI Gene ID: 6122 UniProt ID: P35978
RPL3 encodes Ribosomal Protein L3, a fundamental component of the large (60S) ribosomal subunit. As one of approximately 47 ribosomal proteins in the eukaryotic 60S subunit, RPL3 plays essential roles in ribosome assembly, protein synthesis, and specifically the peptidyl transferase catalytic activity that underlies peptide bond formation. While traditionally viewed as a "housekeeping" protein essential for cell survival, emerging research reveals important neuron-specific functions and clear dysregulation in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). RPL3 has emerged as a critical player in synaptic protein synthesis, neuronal stress responses, and the regulation of disease-specific protein translation.
RPL3 is particularly notable for its position at the peptidyl transferase center (PTC) of the ribosome, where it directly contributes to the catalytic mechanism of peptide bond formation. This central role in protein synthesis makes RPL3 a key determinant of translational capacity in neurons, which have exceptionally high protein synthesis demands due to their complex morphology, synaptic plasticity requirements, and long axonal projections. The dysfunction of RPL3 in neurodegeneration thus represents a fundamental impairment of cellular proteostasis that cascades into multiple pathological pathways.
Gene and Protein Structure
Genomic Organization
The human RPL3 gene spans approximately 6.5 kb on chromosome 22q12.1 and consists of:
- 7 exons encoding the mature protein
- 5' UTR containing upstream open reading frames (uORFs) for translational regulation
- 3' UTR containing polyadenylation signals and regulatory elements including AU-rich elements (AREs)
Protein Structure
RPL3 is a 397-amino acid protein with a molecular weight of approximately 43.2 kDa. Key structural features include:
The protein contains:
- RNA-binding motifs: K-rich and R-rich regions for 28S rRNA interaction
- Helix-turn-helix domain: For nucleic acid binding
- GTPase interaction site: For interaction with elongation factors (eEF-1A, eEF-2)
Ribosomal Context
Within the 60S subunit, RPL3 is located:
- At the peptidyl transferase center (PTC)
- Near the factor-binding site
- Adjacent to the GTPase-associated center
- Interacting with the central protuberance (RPL5, RPL11)
Expression Pattern
Tissue Distribution
RPL3 is ubiquitously expressed across all tissues, with highest levels in:
- Brain: Particularly in neurons with high translational activity
- Liver: High metabolic and protein synthesis demand
- Kidney: Active protein synthesis
- Skeletal muscle: High protein turnover
- Testis: Active in spermatogenesis
Brain Regional Expression
Cell-Type Specificity
- Neurons: Very high expression, localized throughout soma, dendrites, and axons
- Astrocytes: Moderate expression
- Microglia: Lower expression, increases with activation
- Oligodendrocytes: Moderate expression, higher in myelinating oligodendrocytes
Role in Neurodegeneration
Alzheimer's Disease (AD)
Ribosomal dysfunction is a well-documented and early feature of AD pathogenesis, with RPL3 playing a central role:
- Binding to ribosomal proteins including RPL3
- Disrupting translation elongation
- Causing ribosomal subunit misassembly
- Reducing polysome stability[@zhang2019]
Parkinson's Disease (PD)
In PD, RPL3 dysregulation contributes to multiple aspects of pathogenesis:
Amyotrophic Lateral Sclerosis (ALS)
RPL3 in ALS pathogenesis:
Frontotemporal Dementia (FTD)
- Translation dysregulation similar to ALS patterns
- RPL3 in stress granule pathology
- Connection to RNA-binding protein diseases including FTD-GRN
Molecular Mechanisms
Protein Synthesis Functions
RPL3 participates in several essential translation processes:
Key Interaction Partners
Translational Control Pathways
mRNA → 43S pre-initiation complex → 48S initiation complex
↓
60S subunit joining
↓
RPL3-PTC function
↓
Peptide bond formation
↓
Elongation → Termination
Stress Response Integration
RPL3 serves as an integrator of cellular stress responses:
Ribosomal Dysfunction in Neurodegeneration
The Ribosomopathy Concept
Ribosomal dysfunction has emerged as a key mechanism in neurodegeneration, with RPL3 at the crossroads:
Global Translation Deficits in AD/PD
- Reduced polysome abundance in AD and PD brains correlating with disease severity
- Decreased ribosomal RNA levels and ribosomal protein content
- Impaired ribosome assembly machinery
- Selective loss of specific ribosomal proteins including RPL3
Selective Translation Dysregulation
- Certain mRNAs more affected than others in neurodegeneration
- Synaptic transcripts particularly vulnerable to translational repression
- Disease-specific translation patterns affecting critical neuronal proteins
- RPL3 alterations affect specific mRNA translation
Ribosome Quality Control Failure
- Accumulation of stalled ribosomes in disease states
- Defective ribosome recycling
- Ribosome-associated quality control (RQC) pathway impairment
- Collision-induced translational repression
Therapeutic Implications
Targeting Ribosomal Dysfunction
Biomarker Potential
- RPL3 levels in cerebrospinal fluid (CSF) as a biomarker
- Post-translational modifications as disease state indicators
- RPL3 autoantibodies in neurodegenerative disease
Mermaid Diagram: RPL3 in Neurodegeneration
Experimental Evidence
Human Studies
Post-mortem brain studies have consistently demonstrated RPL3 alterations in neurodegenerative diseases:
Animal Models
Cell Culture Studies
Molecular Studies
Synaptic Function and Learning
Synaptic Ribosomes
RPL3 plays critical roles in synaptic function:
Learning and Memory
RPL3 is essential for learning and memory:
Therapeutic Targeting
Small Molecule Approaches
Gene Therapy Approaches
Repurposing Candidates
Biomarker Potential
Cerebrospinal Fluid Biomarkers
- RPL3 levels in CSF correlate with disease progression
- RPL3 autoantibodies as diagnostic markers
- Post-translational modifications as stage indicators
- Comparison with established biomarkers (Aβ, tau, α-syn)
Blood-Based Biomarkers
- Peripheral blood mononuclear cell RPL3
- Exosomal RPL3
- Platelet RPL3 as surrogate
- Longitudinal tracking potential
Imaging Correlations
- RPL3 PET ligand development
- Correlation with FDG-PET hypometabolism
- Structural MRI atrophy patterns
Comparative Biology
Evolutionary Conservation
RPL3 is highly conserved across species:
- Yeast to human: ~88% identity
- Essential gene in all eukaryotes
- Neuron-specific functions acquired in vertebrates
Model Organisms
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/als)
- [Ribosomal Proteins](/entities/ribosomal-proteins)
- [Translation Machinery](/entities/translation-machinery)
- [Synaptic Plasticity](/entities/synaptic-plasticity)
- [Stress Granules](/entities/stress-granules)
- [Integrated Stress Response](/entities/integrated-stress-response)
- [Tau Pathology](/entities/tau-protein)
- [Alpha-Synuclein](/entities/alpha-synuclein)
External Links
- [NCBI Gene - RPL3](https://www.ncbi.nlm.nih.gov/gene/6122)
- [UniProt - RPL3](https://www.uniprot.org/uniprot/P35978)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=RPL3+neurodegeneration)
- [OMIM - RPL3](https://www.omim.org/entry/604377)
Brain Atlas Resources
- [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=RPL3): Gene expression data
- [BrainSpan](https://www.brainspan.org/): Developmental expression
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Mouse expression data
- [Human Protein Atlas](https://www.proteinatlas.org/): Protein expression
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-rpl3 |
| kg_node_id | RPL3 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-00776045e50e |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rpl3'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-rpl3?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[RPL3 — Ribosomal Protein L3](http://scidex.ai/artifact/wiki-genes-rpl3)
http://scidex.ai/artifact/wiki-genes-rpl3